Domain Parters Vii L P - Net Worth and Insider Trading
Domain Parters Vii L P Net Worth
The estimated net worth of Domain Parters Vii L P is at least $44 Million dollars as of 2024-04-27. Domain Parters Vii L P is the 10% Owner of Zogenix Inc and owns about 810,254 shares of Zogenix Inc (ZGNX) stock worth over $22 Million. Domain Parters Vii L P is the 10% Owner of Tobira Therapeutics Inc and owns about 394,813 shares of Tobira Therapeutics Inc (TBRA) stock worth over $17 Million. Domain Parters Vii L P is also the 10% Owner of Esperion Therapeutics Inc and owns about 2,566,935 shares of Esperion Therapeutics Inc (ESPR) stock worth over $5 Million. Besides these, Domain Parters Vii L P also holds Obalon Therapeutics Inc (OBLN) , Clovis Oncology Inc (CLVSQ) , Evoke Pharma Inc (EVOK) , Orexigen Therapeutics Inc (OREXQ) . Details can be seen in Domain Parters Vii L P's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Domain Parters Vii L P has not made any transactions after 2019-08-06 and currently still holds the listed stock(s).
Transaction Summary of Domain Parters Vii L P
Domain Parters Vii L P Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Domain Parters Vii L P owns 11 companies in total, including Obalon Therapeutics Inc (OBLN) , Regado Biosciences Inc (RGDO) , and Evoke Pharma Inc (EVOK) among others .
Click here to see the complete history of Domain Parters Vii L P’s form 4 insider trades.
Insider Ownership Summary of Domain Parters Vii L P
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OBLN | Obalon Therapeutics Inc | 2019-08-06 | 10 percent owner |
| RGDO | Regado Biosciences Inc | 2016-11-01 | 10 percent owner |
| EVOK | Evoke Pharma Inc | 2016-05-26 | 10 percent owner |
| ESPR | Esperion Therapeutics Inc | 2014-10-21 | 10 percent owner |
| EVFM | Evofem Biosciences Inc | 2014-11-19 | 10 percent owner |
| AKAOQ | Achaogen Inc | 2014-03-17 | 10 percent owner |
| TNDM | Tandem Diabetes Care Inc | 2013-11-13 | 10 percent owner |
| CLVSQ | Clovis Oncology Inc | 2013-06-04 | 10 percent owner |
| OREXQ | Orexigen Therapeutics Inc | 2011-12-22 | 10 percent owner |
| ZGNX | Zogenix Inc | 2011-09-16 | 10 percent owner |
| RSLS | Reshape Lifesciences Inc | 2016-10-05 | 10 percent owner |
Domain Parters Vii L P Latest Holdings Summary
Domain Parters Vii L P currently owns a total of 7 stocks. Among these stocks, Domain Parters Vii L P owns 810,254 shares of Zogenix Inc (ZGNX) as of November 29, 2010, with a value of $22 Million and a weighting of 49.13%. Domain Parters Vii L P owns 394,813 shares of Tobira Therapeutics Inc (TBRA) as of May 4, 2015, with a value of $17 Million and a weighting of 37.76%. Domain Parters Vii L P also owns 2,566,935 shares of Esperion Therapeutics Inc (ESPR) as of October 21, 2014, with a value of $5 Million and a weighting of 11.08%. The other 4 stocks Obalon Therapeutics Inc (OBLN) , Clovis Oncology Inc (CLVSQ) , Evoke Pharma Inc (EVOK) , Orexigen Therapeutics Inc (OREXQ) have a combined weighting of 2.02% among all his current holdings.
Latest Holdings of Domain Parters Vii L P
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZGNX | Zogenix Inc | 2010-11-29 | 810,254 | 26.68 | 21,617,577 |
| TBRA | Tobira Therapeutics Inc | 2015-05-04 | 394,813 | 42.09 | 16,617,679 |
| ESPR | Esperion Therapeutics Inc | 2014-10-21 | 2,566,935 | 1.90 | 4,877,177 |
| OBLN | Obalon Therapeutics Inc | 2019-08-06 | 271,144 | 3.05 | 826,989 |
| CLVSQ | Clovis Oncology Inc | 2013-06-04 | 2,581,745 | 0.02 | 38,726 |
| EVOK | Evoke Pharma Inc | 2016-05-26 | 50,523 | 0.46 | 23,140 |
| OREXQ | Orexigen Therapeutics Inc | 2011-12-22 | 296,742 | 0.01 | 1,573 |
Holding Weightings of Domain Parters Vii L P
Domain Parters Vii L P Form 4 Trading Tracker
According to the SEC Form 4 filings, Domain Parters Vii L P has made a total of 0 transactions in Zogenix Inc (ZGNX) over the past 5 years. The most-recent trade in Zogenix Inc is the acquisition of 288,824 shares on November 29, 2010, which cost Domain Parters Vii L P around $9 Million.
According to the SEC Form 4 filings, Domain Parters Vii L P has made a total of 0 transactions in Tobira Therapeutics Inc (TBRA) over the past 5 years. The most-recent trade in Tobira Therapeutics Inc is the acquisition of 30,864 shares on May 4, 2015, which cost Domain Parters Vii L P around $3 Million.
According to the SEC Form 4 filings, Domain Parters Vii L P has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 500,000 shares on October 21, 2014, which cost Domain Parters Vii L P around $10 Million.
More details on Domain Parters Vii L P's insider transactions can be found in the Insider Trading History of Domain Parters Vii L P table.Insider Trading History of Domain Parters Vii L P
- 1
Domain Parters Vii L P Trading Performance
GuruFocus tracks the stock performance after each of Domain Parters Vii L P's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Domain Parters Vii L P is 13.05%. GuruFocus also compares Domain Parters Vii L P's trading performance to market benchmark return within the same time period. The performance of stocks bought by Domain Parters Vii L P within 3 months outperforms 5 times out of 21 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Domain Parters Vii L P's insider trading performs compared to the benchmark.
Performance of Domain Parters Vii L P
Average Return
-14.16%
Outperforming Transactions
19%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.7 | 13.05 | 12.86 | -14.16 | -20.66 | -3.83 |
| Relative Return to S&P 500(%) | 9.85 | 8.46 | 5.49 | -24.61 | -31.67 | -15.54 |
Domain Parters Vii L P Ownership Network
Ownership Network List of Domain Parters Vii L P
Ownership Network Relation of Domain Parters Vii L P
Domain Parters Vii L P Owned Company Details
What does Obalon Therapeutics Inc do?
Who are the key executives at Obalon Therapeutics Inc?
Domain Parters Vii L P is the 10 percent owner of Obalon Therapeutics Inc. Other key executives at Obalon Therapeutics Inc include director & President & CEO & Exec Chairman Andrew P Rasdal , Chief Financial Officer Nooshin Hussainy , and Chief Technology Officer Mark Brister .
Obalon Therapeutics Inc (OBLN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Obalon Therapeutics Inc (OBLN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Obalon Therapeutics Inc (OBLN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Obalon Therapeutics Inc (OBLN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Obalon Therapeutics Inc Insider Transactions
Domain Parters Vii L P Mailing Address
Above is the net worth, insider trading, and ownership report for Domain Parters Vii L P. You might contact Domain Parters Vii L P via mailing address: One Palmer Square Suite 515, Princeton Nj 08542.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
